Develops versatile polymer–lipid nanocarriers for safe, efficient, cell-targeted delivery of RNAs, with emphasis on non-coding RNAs. Creates nanotherapeutics for neuromuscular and heart diseases and research-use kits, aimed at reducing costs and accelerating RNA therapy development.